Title |
46,XY disorder of sex development due to 17-beta hydroxysteroid dehydrogenase type 3 deficiency: a plea for timely genetic testing
|
---|---|
Published in |
International Journal of Pediatric Endocrinology, June 2016
|
DOI | 10.1186/s13633-016-0030-x |
Pubmed ID | |
Authors |
Chelsey Grimbly, Oana Caluseriu, Peter Metcalfe, Mary M. Jetha, Elizabeth T. Rosolowsky |
Abstract |
17β-hydroxysteroid dehydrogenase type 3 (17βHSD3) deficiency is a rare cause of disorder of sex development (DSD) due to impaired conversion of androstenedione to testosterone. Traditionally, the diagnosis was determined by βHCG-stimulated ratios of testosterone:androstenedione < 0.8. An otherwise phenotypically female infant presented with bilateral inguinal masses and a 46,XY karyotype. βHCG stimulation (1500 IU IM for 2 days) suggested 17βHSD3 deficiency although androstenedione was only minimally stimulated (4.5 nmol/L to 5.4 nmol/L). Expedient genetic testing for the HSD17B3 gene provided the unequivocal diagnosis. We advocate for urgent genetic testing in rare causes of DSD as indeterminate hormone results can delay diagnosis and prolong intervention. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 19 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 5 | 26% |
Student > Bachelor | 3 | 16% |
Researcher | 2 | 11% |
Student > Master | 1 | 5% |
Lecturer > Senior Lecturer | 1 | 5% |
Other | 2 | 11% |
Unknown | 5 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 12 | 63% |
Agricultural and Biological Sciences | 2 | 11% |
Unknown | 5 | 26% |